Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
70
self-reported 11–50 band
Founded
Not recorded
Legal entities
1
ABR
Office countries
2
3 addresses
Funding rounds
4
Post IPO debt · Jul 2025 · US$ 20.2M
Company type
Public Company
self-reported
Legal entity
1 brand → 1 confirmed entity
BOTANIX PHARMACEUTICALS LTD
ABN70009109755
Legal entities
Show as table · Botanix Pharmaceuticals: 1 registry entity
| BOTANIX PHARMACEUTICALS LTD | ABN 70009109755 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Botanix is an ASX-listed dermatology company based in Philadelphia and Phoenix (USA) that is committed to the development and commercialisation of novel treatments for common skin diseases and infections.
The Company’s lead product is a novel treatment for primary axillary hyperhidrosis, a medical condition where excessive sweating occurs beyond what is needed to maintain body temperature, which impacts the lives of more than 15 million people in the US alone. This product is backed by successful Phase 3 clinical studies, is already approved in Japan, and is in the final stages of US regulatory clearance.
The broader clinical pipeline targets unmet needs in dermatology (including acne, rosacea and dermatitis) as well as infections, and are underpinned by well-controlled, randomised clinical trials.
Botanix has attracted a world-class team and significant capital to support the development and commercialisation of its products.
Specialties
All 6 specialties
- hyperhidrosis
- rosacea
- dermatitis
- acne
- antimicrobial
- Medical dermatology
Locations
2
Countries with an office address3 addresses on record
AustraliaprimaryUnited States
Country footprint
Show as table · Offices in 2 countries
| Countries | 2 |
|---|---|
| Primary country | AU |
All codes: AU US
Addresses
- AU41 – 47 Colin Street; Ste 3; West Perth, WA 6005Primary
- US2390 E Camelback Rd; Ste 202; Phoenix, Arizona 85016
- US100 Front St; Ste 1340; Conshohocken, PA 19428
Grid intelligence Members
Funding
Rounds4
Round typePost IPO debt · non-equity funding
Amount (USD)20,200,000
Stage rank6
Investors named1
Since last round6 mo
Funding
Show as table · 4 funding rounds
| Rounds | 4 |
|---|---|
| Axis | 2025 to 2027 |
| Post IPO debt · 10 Jul 2025 | US$ 20.2M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
Which legal entity operates under Botanix Pharmaceuticals?
One Western Australia entity on the ABR. BOTANIX PHARMACEUTICALS LTD (ABN 70 009 109 755), high confidence.
How many people work at Botanix Pharmaceuticals?
The record holds 70 counted staff profiles at January 2026, above the self-reported 11–50 band.
Where does Botanix Pharmaceuticals have offices?
Three addresses on record across 2 countries. Primary: 41 – 47 Colin Street, Ste 3, West Perth, WA 6005.
Has Botanix Pharmaceuticals raised funding?
Four rounds. Latest 10 July 2025: post IPO debt, US$20,200,000, investor Kreos Capital.
What does Botanix Pharmaceuticals list as its specialties?
Six tags on the brand's own list, among them acne.
Which companies are listed alongside Botanix Pharmaceuticals?
21 profiles list Botanix Pharmaceuticals as a peer — 94th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Little Green Pharma lists it back.